More questions than answers at Walgreen

Walgreen (WAG) felt pressure on pharmacy margins during FQ3 (earnings, details) with third-party reimbursements lower.

Though the forecast for cost savings from the company's merger with Alliance Boots was pushed higher, visibility on the integration is still cloudy with key decisions still hanging in the balance. A potential tax inversion move tops the list.

Walgreen pulled its 2016 guidance and put investors into a waiting period until later this summer for more clarity.

WAG -2.2% premarket

From other sites
Comments (3)
  • JD in NJ
    , contributor
    Comments (1635) | Send Message
    Down 2.2%?


    Oh noes! That means my WAG is only up about 85% over the past couple of years now.
    24 Jun 2014, 09:11 AM Reply Like
  • kylempls
    , contributor
    Comments (59) | Send Message
    Gotta love it!! And love the 80+ straight qtrs of increasing dividends.
    25 Jun 2014, 01:08 PM Reply Like
  • MagpieLights
    , contributor
    Comment (1) | Send Message
    Yea and their employees are getting squeezed like crazy, including highly educated pharmacists.
    24 Jun 2014, 09:12 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs